SSC-COVID in Patients After COVID-19

NCT05233553 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2022-02-10

No results posted yet for this study

Summary

Analysis of occurrence of SSC-COVID in SARS-CoV-2-patients after the first wave of COVID-pandemic

Conditions

  • Secondary Sclerosing Cholangitis
  • COVID-19

Interventions

OTHER

control of liver enzymes

follow-up with clinical and laboratory measurements

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2021-12-31
Completion
2022-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05233553 on ClinicalTrials.gov